دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk
Daniel O’Hair, MD1; Steven J. Yakubov, MD2; Kendra J. Grubb, MD3; Jae K. Oh, MD4; Saki Ito, MD4; G. Michael Deeb, MD5,6; Nicolas M. Van Mieghem, MD, PhD7; David H. Adams, MD8; Tanvir Bajwa, MD9; Neal S. Kleiman, MD10,11; Stanley Chetcuti, MD5,6; Lars Søndergaard, MD12; Hemal Gada, MD13,14; Mubashir Mumtaz, MD13,14; John Heiser, MD15,16; William M. Merhi, DO15,16; George Petrossian, MD17; Newell Robinson, MD17; Gilbert H. L. Tang, MD, MSc, MBA8; Joshua D. Rovin, MD18; Stephen H. Little, MD10,11; Renuka Jain, MD19; Sarah Verdoliva, MSc20; Tim Hanson, PhD20; Shuzhen Li, PhD20; Jeffrey J. Popma, MD20; Michael J. Reardon, MD10,11
doi : 10.1001/jamacardio.2022.4627
February 2023, Vol 8, No. 2, Pages 104-207
Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies
Ashwin S. Nathan, MD, MS1,2,3,4; Kriyana P. Reddy, BS2; Lin Yang, MS2,3; Lauren A. Eberly, MD, MPH1,2,3; Elias J. Dayoub, MD, MPP, MSHP1,2,3; Sameed A. M. Khatana, MD, MPH1,2,3,4; Howard M. Julien, MD, MPH1,2,3,4; Nimesh D. Desai, MD, PhD2,3,5; Wilson Y. Szeto, MD5; Howard C. Herrmann, MD1; Taisei J. Kobayashi, MD1,2,3,4; Paul Fiorilli, MD1,4; Wayne B. Batchelor, MD6; Roxana Mehran, MD7; Mohamad Adnan Alkhouli, MD8; Jay Giri, MD, MPH1,2,3,4; Peter W. Groeneveld, MD, MS2,3,4,9; Alexander C. Fanaroff, MD, MHS1,2,3
Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary Prevention
Nicholas A. Marston, MD, MPH1; James P. Pirruccello, MD2,3,4; Giorgio E. M. Melloni, PhD1; Satoshi Koyama, PhD2,3,5; Frederick K. Kamanu, PhD1; Lu-Chen Weng, PhD2,3; Carolina Roselli, MS2; Yoichiro Kamatani, MD, PhD6; Issei Komuro, MD, PhD7; Krishna G. Aragam, MD2,3; Adam S. Butterworth, PhD8,9,10,11; Kaoru Ito, MD, PhD5; Steve A. Lubitz, MD, MPH2,3; Patrick T. Ellinor, MD, PhD2,3; Marc S. Sabatine, MD, MPH1; Christian T. Ruff, MD, MPH1
Performance of Cardiovascular Risk Prediction Models Among People Living With HIVA Systematic Review and Meta-analysis
Cullen Soares, MD1; Michael Kwok, MSc2; Kent-Andrew Boucher, MD3; Mohammed Haji, MD2; Justin B. Echouffo-Tcheugui, MD, PhD4; Christopher T. Longenecker, MD5; Gerald S. Bloomfield, MD, MPH6; David Ross, MD, PhD7,8; Eric Jutkowtiz, PhD9,10,11; Jennifer L. Sullivan, PhD9,11; James L. Rudolph, MD, SM2,9,10,11,12; Wen-Chih Wu, MD, MPH2,9,11,12; Sebhat Erqou, MD, PhD2,9,10,12
Associations Between New York Heart Association Classification, Objective Measures, and Long-term Prognosis in Mild Heart FailureA Secondary Analysis of the PARADIGM-HF Trial
Luis E. Rohde, MD, ScD1,2; André Zimerman, MD, PhD1,2; Muthiah Vaduganathan, MD, MPH3; Brian L. Claggett, PhD3; Milton Packer, MD4; Akshay S. Desai, MD3; Michael Zile, MD5; Jean Rouleau, MD6; Karl Swedberg, MD7; Martin Lefkowitz, MD8; Victor Shi, MD8; John J. V. McMurray, MD9; Scott D. Solomon, MD3
Association of PCSK9 Loss-of-Function Variants With Risk of Heart Failure
Linea C. Trudsø, MSc1,2; Jonas Ghouse, MD, PhD1,2; Gustav Ahlberg, MSc, PhD1,2; Henning Bundgaard, MD, DMSc3,4; Morten S. Olesen, MSc, PhD1,2
Frailty and Effects of a Multidomain Physical Rehabilitation Intervention Among Older Patients Hospitalized for Acute Heart FailureA Secondary Analysis of a Randomized Clinical Trial
Ambarish Pandey, MD, MSCS1; Dalane W. Kitzman, MD2,3; M. Benjamin Nelson, MS2; Amy M. Pastva, PT, MA, PhD4; Pamela Duncan, PT, PhD5; David J. Whellan, MD6; Robert J. Mentz, MD7; Haiying Chen, PhD8; Bharathi Upadhya, MD2; Gordon R. Reeves, MD, MPT9
Association of Interleukin 6 Inhibition With Ziltivekimab and the Neutrophil-Lymphocyte RatioA Secondary Analysis of the RESCUE Clinical Trial
Nicholas H. Adamstein, MD1; Jan Hein Cornel, MD, PhD2; Michael Davidson, MD3; Peter Libby, MD4; Alessandra de Remigis, MD5; Camilla Jensen, MSc5; Kathrine Ekström, MD, PhD5; Paul M Ridker, MD, MPh1,4
Sorrow on the Shoreline
Megan A. Brandeland, MD1; Alexandra Schick, MD2; Caroline White, MSW, LICSW3
Science and ART—Cardiovascular Disease Risk Assessment in HIV
Matthew J. Feinstein, MD, MSc1
Public Access to Scientific Research Findings and Principles of Biomedical Research—A New Policy for the JAMA Network
Kirsten Bibbins-Domingo, PhD, MD, MAS1; Brian Shields, MBA2; John Z. Ayanian, MD, MPP3,4; Robert O. Bonow, MD, MS5,6; Neil M. Bressler, MD7,8; Dimitri Christakis, MD, MPH9,10; Mary L. Disis, MD11,12; S. Andrew Josephson, MD13,14; Melina R. Kibbe, MD15,16; Dost Öngür, MD, PhD17,18; Jay F. Piccirillo, MD19,20; Rita F. Redberg, MD, MPH21,22; Frederick P. Rivara, MD, MPH23,24; Kanade Shinkai, MD, PhD25,26; Thomas J. Easley27
Transforming Atrial Fibrillation Research to Integrate Social Determinants of HealthA National Heart, Lung, and Blood Institute Workshop Report
Emelia J. Benjamin, MD, ScM1,2; Kevin L. Thomas, MD3; Alan S. Go, MD4,5,6,7; Patrice Desvigne-Nickens, MD8; Christine M. Albert, MD, MPH9; Alvaro Alonso, MD, PhD10; Alanna M. Chamberlain, PhD11,12; Utibe R. Essien, MD, MPH13; Inmaculada Hernandez, PharmD, PhD14; Mellanie True Hills, BS15; Kiarri N. Kershaw, PhD, MPH16; Phillip D. Levy, MD, MPH17; Jared W. Magnani, MD, MSc13; Daniel D. Matlock, MD, MPH18,19; Emily C. O’Brien, PhD20; Carlos J. Rodriguez, MD, MPH21; Andrea M. Russo, MD22; Elsayed Z. Soliman, MD, MS23; Lawton S. Cooper, MD, MPH8; Sana M. Al-Khatib, MD, MHS3
doi : 10.1001/jamacardio.2022.4091
Only modest attention has been paid to the contributions of social determinants of health to atrial fibrillation (AF) risk factors, diagnosis, symptoms, management, and outcomes.
Fundamental Pathobiology of Coronary Atherosclerosis and Clinical Implications for Chronic Ischemic Heart Disease Management—The Plaque HypothesisA Narrative Review
Peter H. Stone, MD1; Peter Libby, MD1; William E. Boden, MD2
doi : 10.1001/jamacardio.2022.3926
Recent clinical and imaging studies underscore that major adverse cardiac events (MACE) outcomes are associated not solely with severe coronary obstructions (ischemia hypothesis or stenosis hypothesis), but with the plaque burden along the entire coronary tree.
A Case of Right Bundle Branch Block With Changing Axis
Robert B. King, MD1; Ramil Goel, MD2,3
Exertional Dyspnea in a Female Patient Aged 55 Years Without Significant Medical History
Sk Minhajuddin Siraj, DM1; Ritwik Ghosh, MD2; Dipayan Roy, MD, DNB3,4
Further Characterizing Cardiomyopathy Mortality in Young Adults to Elucidate Health Disparities
Samshita Yalamanchili, MD1; Jeffrey A. Shih, MD1; Lara C. Kovell, MD1
Further Characterizing Cardiomyopathy Mortality in Young Adults to Elucidate Health Disparities—Reply
Abdul Mannan Khan Minhas, MD1; Sadiya S. Khan, MD, MSc2; Muhammad Shahzeb Khan, MD, MSc3
Cholesteryl Ester Transfer Protein Inhibitors and Access to the Retina in Age-Related Macular Degeneration
Christine A. Curcio, PhD1; Mark Johnson, PhD2
Cholesteryl Ester Transfer Protein Inhibitors and Access to the Retina in Age-Related Macular Degeneration—Reply
Liv Tybjærg Nordestgaard, MD, PhD1; Børge Grønne Nordestgaard, MD, DMSc2,3,4,5; Anne Tybjærg-Hansen, MD, DMSc1,3,4,5
Equity in Clinical Trial Participation Requires Equity in Identification and Treatment of Valvular Heart Disease
Ann Marie Navar, MD, PhD1,2
Cardiovascular Disease Risk Prediction in Young Adults—The Next Frontier
Sadiya Sana Khan, MD, MSc1,2; Michael J. Pencina, PhD3,4
